Israeli researcher finds that a combination of THC, CBC, and CBG shows anticancer activity against ovarian cancer cells. The cannabinoids also worked well with niraparib—a common chemotherapy drug—but not at all with gemcitabine, another chemotherapy drug.

AJEM interviews Israeli cannabis researcher David Meiri, PhD, after his keynote address at CannMed '23 in Marco Island, Florida.

In a survey of 101 patients from a single ambulatory palliative care practice in Georgia with medical cannabis cards, 96% believed that cannabis was important for pain management, researchers reported in the Journal of Palliative Medicine. In addition, a majority of those patients with cancer reported cannabis as being important for cancer cure (59%). A…

Adjunctive use of plant-derived cannabidiol was associated with improved life expectancy in patients with glioblastoma multiforme, according to a case series published in Anticancer Research.  The study included 9 patients who were given a daily CBD dose of 400 mg in addition to standard treatment with maximal resection followed by radiochemotherapy.  At the time of…